NewsBite

Healthcare

Today

Melbourne’s John Fawkner Hospital is a Healthscope-owned facility; Bupa’s dispute with the hospital group has escalated as pressure on private health insurers grows.

Breathing room: Healthscope lenders in standstill vote

Instead of preparing Healthscope for a float, Brookfield has been forced to inject emergency funding into the company.

Yesterday

Ramsay Health Care CEO Natalie Davis.

Ramsay says Labor’s premium hike will not cover soaring hospital costs

Still, shares in the country’s largest private hospital operator rose sharply after it appointed Goldman Sachs to assess the sale of its European business.

This Month

Telix boss Christian Behrenbruch is cashed up.

Telix Pharma CEO in $120m block trade; taps JPMorgan

Telix boss Christian Behrenbruch and the other seller had agreed to a 12-month escrow.

John Boland, prostate cancer drug patient.

Big pharma sues GenesisCare over Labor-endorsed copycat cancer drug

Swiss pharma giant Novartis is taking legal action against the Australian cancer care provider as a dispute over how to fund and regulate nuclear medicines escalates.

Prime Minister Anthony Albanese in Launceston for the launch of Labor’s $8.5 billion Medicare pledge.

Why a Mediscare campaign won’t be so easy this time around

Labor’s Medicare package offers politically popular relief for GP visits but may not convince voters losing confidence in Australia’s public health system.

Advertisement
Doctors Hamish Meldrum (pictured) and Ross Lamplugh founded Ochre Health in 2002.

Genesis Capital gets back into general practice with Ochre Health

Genesis has partnered with doctor Hamish Meldrum who will keep a significant shareholding in the business.

In the medical business the unfair term ‘frequent flyers’ is used to describe patients who through no fault of their own can only find the care they need in public hospitals

My patient Shirley would benefit from more bulk billing. Here’s why she won’t

Labor is shining an 8.5 billion-watt spotlight on general practices to divert attention from the elephant in the room that everyone in Australia has seen.

Doctors are swapping tips on how to game the Medicare system.

Doctors say not all GP visits will be free under Labor plan

Medical professionals welcome the $8.5 billion Medicare overhaul but urge targeted funding to care for patients who need it most.

Health Minister Mark Butler and Prime Minister Anthony Albanese are set to unveil the biggest investment in Medicare in 40 years.

Albanese makes $8.5b Medicare overhaul his signature election policy

The prime minister will make Medicare the centrepiece of his re-election campaign, promising to spend big to eliminate patient costs for visits to the doctor.

ASX-listed Telix Pharmaceuticals’ new Belgian plant opened on June 8 after a three-year development phase.

Star biotech Telix makes $1.2b revenue pledge

The Melbourne-based nuclear medicine company is expected to be a major player in the US radiopharmaceutical market.

Sales of Mayne Pharma’s birth control pills and other women’s health products have underpinned the company’s improved performance this year.

US pharma giant Cosette makes $672m bid for Mayne Pharma

US pharma giant Cosette has offered $7.40 a share for Mayne Pharmaceuticals, a premium to recent trading but a fraction of the $42 it was trading at in 2016.

Ramsay’s global CFO search for a hospital pass job

Does the healthcare outfit really think someone will move to Australia to manage the colossal mess that is our private hospital market?

Healthscope to close maternity wards in Darwin and Hobart

The Coalition has seized on the shutdowns to accuse Labor of failing to take action to stop the closure of critical health service

David Di Pilla’s HMC Capital has a track record in tough deals. Is Healthscope too tough?

David Di Pilla thinks a new PE owner could save Healthscope

Property is at the heart of the veteran deal maker’s plans for the private hospitals operator – just as it was at Masters almost a decade ago.

A shot of semaglutide, sold in Australia as Wegovy, can be used to treat heart disease under a ruling by the medicines’ regulator.

TGA approves weight-loss drug to treat heart disease

Regulators say the weight-loss drug Wegovy can now be used to treat more than 3 million overweight Australians with heart disease.

Advertisement
Not for profit hospitals say the system is at breaking point as they call for funding help from the government and insurers.

Catholic Health’s new plan to fix hospitals at ‘breaking point’

Private hospital groups have sent Labor a package of proposals they say can save the struggling sector.

David Di Pilla has been approached by potential partners to takeover operating Healthscope operators.

David Di Pilla’s HMC Capital eyes Healthscope hospitals

The alternative asset manager and other operators are talking to Healthscope’s landlords about taking over Australia’s second-biggest hospital group.

Cochlear chief executive Dig Howitt says cost of living pressures in the United States are hurting services revenues.

Cochlear says US cost-of-living pressures hit services revenue

Cochlear expects full-year earnings to come in at the lower end of guidance, despite rising sales of its implants.

.

Chemist Warehouse scores $34b pay day in ASX debut

The founders were on hand as the retailer made its sharemarket debut on Thursday via Sigma, with plans to expand in Australia and globally.

Is Ramsay Health Care whipping itself into a frenzy?

The private hospital lobby is turning on itself and Labor is making mileage from it.

Original URL: https://www.afr.com/topic/healthcare-5y6